CLDN2 and laryngotracheoesophageal cleft: This design allowed us to rapidly discover and validate eight proteins, namely p53, ETHE1, CTAG1A, C1QTNF1, TEX264, CLDN2, NSG1, and HRas, as biomarkers for LC early diagnosis.